Clinical Trial Update: SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents [Phase 4]

View source ↗

Summary

Phase 4 trial update on intracoronary brachytherapy for recurrent restenosis after multiple drug-eluting stents in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Restenosis

Snippet

Sponsor: Scripps Health | Conditions: Coronary Artery Disease, Coronary Restenosis | Phase 4 | Status: COMPLETED